Pyschological Stress can induce Oxidative Stress-mediated Vascular Injury
|
|
- Derrick King
- 5 years ago
- Views:
Transcription
1 Pyschological Stress can induce Oxidative Stress-mediated Vascular Injury Ick-Mo Chung, MD, PhD Cardiology Division Ewha Womans University
2 Contents Evidence of psychological stress as a risk factor for CAD Possible underlying mechanism by which psychological stress injure the vessel - Oxidative stress : ROCK, RGS - Inflammation
3 Allostatic Load Allostasis: ability to achieve stability through change Allostatic load: long term effect of physiological response to Stress McEwen BS. N Engl J Med 1998;338:171
4 Psychological stress as a risk factor for CVD Psychological stress is estimated as an emerging risk factor for atherosclerosis. - Stress: threatened homeostasis provoked by stressor. - Psychological factors contribute to the development and progression of CAD: depression, anxiety, personality and character traits, social isolation, and chronic life stress Physiological response to stress is mediated by the activation of sympathetic nervous system (SNS) and hypothalamic pituitary adrenal (HPA) axis. Stress can induce inflammation in peripheral organ through neuroendocrine system
5 Social stress and Atherosclerosis in normocholesterolemic monkeys Rate of aggressionφ Severe aggression % Rate of submission Severe submission % Time in affiliation % Stress (n=15) * * 21.0* Control (n=14) Intimal area (mm 2 ) Φ median rates of performance per hour per monkey, * p<0.05 Arteries with plaques 11/15 (stress) vs 4/14 (control) p< stress s control Kaplan JR. Science.1983;220:
6 Anger proneness predicts CHD risk Prospective analysis from the Atherosclerosis Risk In Communities (ARIC) Study Williams JE. Circulation. 2000;101: Aim 1. dose-response relation between anger and CHD risk 2. relation of CHD free survival with anger level Methods Prospective design (median 53 mo, 6yr Max. f/u) ARIC study (n=13,208) white and black men and women (45-64 yr) without CHD 10-item Spielberger Trait Anger Scale CHD events: acute MI/fatal CHD (hard event), silent MI, revascularization procedure
7 CHD event free survival probabilities by Trait Anger scores Normotensive Hypertensive P=NS P=.001 Williams JE. Circulation. 2000;101:
8 Intensive lifestyle changes for reversal of CHD Ornish D. JAMA. 1998;280: Lifestyle Heart Trial (JAMA1983;249:54-9) Comprehensive lifestyle changes (1 yr) without lipid lowering drug could reduce LDL-chol by 37% and reduce frequency of angina attack by 91% Aims Effect of sustained lifestyle changes on risk factors, coronary atherosclerosis, and cardiac events after 4 additional yr. Patients: angiography-proven CAD Pts Intensive Lifestyle Program 10% fat vegetarian diet, moderate aerobic exercise, stress management, smoking cessation, and group psychosocial support for 5 yrs avoid simple sugars, emphasize intake of complex carbohydrates and other whole foods
9 Angina symptoms Cardiac events during 5 yr f/u * * *
10 Mean percentage diameter stenosis P=.001 P=.02 Ornish, D. et al. JAMA 1998;280:
11 Reduction in the incidence of type II DM with lifestyle intervention or metformin Diabetes Prevention Program Research Group N Engl J Med 2002;346:393 Question Does a lifestyle intervention or Tx with metformin prevent or delay the onset of DM? Inclusion criteria BMI: 24, plasma glucose: (AC) mg/dl, PC mg/dl - Standard lifestyle with metforrmin 850 mg bid : food guide pyramid NCEP step 1 diet - Intensive lifestyle modification 16-session curriculum covering diet, exercise, and behavior modification, weight reduction >7% through a healthy low calorie, low fat diet, moderate physical activity s/a brisk walking 150 min /wk
12 Cumulative incidence of DM P<.001 Diabetes Prevention Program Research Group NEJM. 2002;346:
13 MDA final / MDA baseline e-nos mrna/ β actin mrna ** ** MDA * stress losartan ramipril control enos mrna * ** * * NOx final / NOx baseline Immobilization stress induces changes in ROS Plasma NOx ** ** ** * stress losartan ramipril control *p<0.05, **p<0.01, p<0.05 for final vs baseline M±SEM 0.0 stress losartan ramipril control Chung I-M & Kim YM Circ Res 2004;93:1523 (abstr)
14 Changes in Ach-induced arterial relaxation stress losartan ramipril control ** ** ** ** ** ** *p<0.05 **p<0.01 p=0.086 M±SEM Relaxation (%) * ** ** Concentration of Ach (log 10 M)
15 Immobilization stress can enhance expression of VCAM-1 VCAM-1 % VCAM-1 positive cells * *p<0.01 vs stress p=0.086 vs stress * <10% 10% VCAM-1 EC EC Stress SD AA 0 stress losartan ramipril control Control SD AA Bar: 50 μm
16 Effect of CUS on NF-κB activation induced by LPS or saline (SAL) in the frontal cortex (A), hypothalamus (B), or hippocampus (C) Munhoz, C. D. et al. J. Neurosci. 2006;26:
17 Plasma IL-6 and NF-κB DNA Binding in PBMC of Patients With Major Depression After a Psychosocial Stressor Challenge Miller AH, Am J Psychiatry 2006;163:1630
18 Neurogenic Inflammation in Stress Both somatic and autonomic nerves are associated with inflammatory cells, and nervous transmission may result in neurogenic inflammation : Nervous innervation is a requirement for establishing certain inflammatory reaction: eg. rhematoid arthritis Direct linkage between neurogenic stimulation and proinflammatory cytokine release - contributing inflammatory mediators in stress PGE2: + SN ending Neuropeptide Y: cotransmitter of SN innervation promotes SMC proliferation, enhances leukocyte adhesion, platelet aggregation, and MΦ activation CRF: + in SN ending, sensory N, spinal cord Substance P: + in autonomic N, ganglia, spinal cord, IL-6: + in sensory N, autonomic N
19 Vascular Injury mediated through Oxidative Stress Response to injury Hypothesis Injury to the endothelium might precipitate the atherosclerotic process (Virchow R, 1856) Atherosclerotic lesions result from an excessive inflammatoryfibroproliferative response various forms of insult to the endothelium and smooth muscle of the artery wall (Ross R,Nature. 1993) Oxidative stress, an excessive production of ROS outstripping antioxidant defense systems, has been implicated in many pathophysiological conditions in cardiovascular systems (atherosclerosis, hypertension, restenosis, smoking, hypercholesterolemia, DM, hypertension, heart failure), cancer, and neurodegeneration.
20 Vascular ROS 10 x Griendling KK et al. Circulation.2003;108:1912-6
21 Peroxynitrite (ONOO - ) strong oxidant: oxidative damage of DNA, RNA, proteins, lipids Mediator of protein nitration Promotes inflammatory synthesis of prostaglandin by activating cyclooxygenase (COX) Attack prostacyclin synthase (Tyr nitration?): Accumulating PGH 2 can activate thromboxane receptors, thereby promoting vasoconstriction Deactivate anti-inflammatory agents Activate c-jun-nh 2 -terminal kinase (JNK) thereby inducing a wide range of stress-related responses including apoptosis Protective role: microbicidal agent, limit bleeding Beckman JS, Circ Res 2001;89:295
22 Potential sources of ROS * rac1, AngII, TNF-α, thrombin, PDGF * Griendling KK et al. Circulation.2003;108:1912-6
23 Consequences of NAD(P)H oxidase activation Harrison DG, 2003;24:
24 Peroxynitrite can increase MMP2 activity Effect of ONOO - on gelatinolytic activity in human SMCs Effect of ONOO - on collagenolytic activity in human SMCs Gallis ZS, J Clin Invest 1996;98:2572 Fluorographic image of 3 H-type IV collagen
25 Regulation of myosin II in SMC and non-muscle cells AT1R IL-1β Somlyo AP. J Phys 2000;522:1777
26 Regulation of enos by ROCK Liao JK, Am J Physiol Cell Physiol 290: C661-C668, 2006
27 Ang II-mediated coronary vascular hypertrophy: role of Rho-kinase Shimokawa H. Circ Res 2003;93:767-75
28 Ang II-mediated vascular macrophage accumulation Role of Rho-kinase Shimokawa H. Circ Res 2003;93:767-75
29 Ang II-mediated NADPH oxidase: Role of Rho-kinase Shimokawa H. Circ Res 2003;93:767-75
30 ROCK inhibition improves endothelial function in CAD Nohria A. et al. Circ Res. 2006;99:1426
31 Active ROCK-α associates with Insulin Receptor Substrate-1 and inhibits insulin signaling in VSMCs Begum N, J Biol Chem 2002;277:6214
32
33 Ang II induce expression and activation of ROCK via NF-κB in vivo Shimokawa H, J Mol Cell Cardiol 2004;37:537
34 AbdAlla S et al. Cell 2004;119:343-54
35 Mononuclear phagocytes in atherogenesis Libby P. Nature 2002;420:868
36 G-Protein coupled Receptor (G-PCR) Signaling Model 23 known Gα protein Gα(s/olf) Gα(i1/i2/i3/t-rod/t-con/gust/z) Gα(q/11/14/16) Gα(12/13) AC GIRK, ERK1/2, JNK, PI3Kr, PLCβ/-ε MAPKs etc. McCudden CR. CMLS 2005;62:551
37 GPCR signaling & Cariovascular disease G αq transgenic overexpression mediates changes in heart function leading to hypertrophy (D Angello D. PNAS197;94:8121). RGS2+/- and RGS2-/- are hypertensive and show prolonged response of the vasculature to vasoconstrictor in vivo. (Heximer SP, J Clin Invest 2003) Transgenic overexpression of RGS4 in aortic coarctation mice model reduced ventricular hypertrophy and rapid decompensation (Rogers JH. J Clin Invest 1999)
38 Differential expression of RGS proteins in each vascular segments mrna fold change RGS1 RGS2 RGS3 RGS4 RGS8 RGS16 RGS5 * RGS5 mrna fold change p<0.05 vs TA of * RGS2 RGS3 RGS4 RGS5 RGS16 0 CCA TA AA CIA MA PA IVC 0 Chung I-M & Schwartz SM. AHA 2006
39 Decreased arterial contraction in abdominal vs thoracic aorta Force (mn) A TA, AA * * * Force (mn) B [Angiotensin II] (nm) [Phenylephrine] (µm)
40 AT1R-stimulated NFAT Activation in Cardiac Fibroblast Kurose H. J Biol Chem. 2005;280:
41 G12/13 mediate Ang II-induced ROS production Fujii, T. et al. J. Biol. Chem. 2005;280:
42 AT1 receptor Oxidative stress Monocytes attraction-mcp-1 Activation CD11b/18 expression Hematopoiesis Endothelial cells Endothelial dysfunction ICAM-1,VCAM-1 Apoptosis Growth factors Cytokines VSMC Contraction Migration Proliferation Apoptosis Cytokines growth factors Matrix metalloproteinase Lipids Oxidation oxldl-uptake Lox-1-expression Coagulation PAI-1 tpa Plaque formation Endothelial dysfunction Plaque rupture-thrombosis
43 Psychological Stress-mediated CV disease RAS, NE, Ach, etc SNS PVN_Hupothalamus CRH HPA Neuropeptides ex. Substance P? Locus Coeruleus NE Ant Pituitary gl POMC: ACTH,GH β-endorphin α-msh Neurogenic Inflammation? Adrenal medulla E & NE RAS ROCK Adrenal cortex corticosteroid Oxidative stress Endoth dysfunction Inflammation Insulin resistance CV remodeling & hypertrophy
Adipose Tissue as an Endocrine Organ. Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University
Adipose Tissue as an Endocrine Organ Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University Functions of Adipose Tissue Adipose tissue expresses and secretes a variety of bioactive peptides,
More informationCardiovascular Protection and the RAS
Cardiovascular Protection and the RAS Katalin Kauser, MD, PhD, DSc Senior Associate Director, Boehringer Ingelheim Pharmaceutical Inc. Micardis Product Pipeline Scientific Support Ridgefield, CT, USA Cardiovascular
More informationEffects of the angiotensin II type-1 receptor antagonist telmisartan on endothelial activation induced by advanced glycation endproducts
Effects of the angiotensin II type-1 receptor antagonist telmisartan on endothelial activation induced by advanced glycation endproducts Serena Del Turco, Teresa Navarra, Giuseppina Basta, Raffaele De
More informationPHM142 Lecture 4: Platelets + Endothelial Cells
PHM142 Lecture 4: Platelets + Endothelial Cells 1 Hematopoiesis 2 Platelets Critical in clotting - activated by subendothelial matrix proteins (e.g. collagen, fibronectin, von Willebrand factor) and thrombin
More informationThe Study of Endothelial Function in CKD and ESRD
The Study of Endothelial Function in CKD and ESRD Endothelial Diversity in the Human Body Aird WC. Circ Res 2007 Endothelial Diversity in the Human Body The endothelium should be viewed for what it is:
More informationBiotherapy of Arteriosclerosis
Biotherapy of Arteriosclerosis Clinical Significance Non-pharmacological & Pharmacological intervention Pathogenesis related with Ang II-mediated oxidative stress Ick-Mo Chung, MD, PhD Division of Cardiology
More informationNovel Markers of Arterial Dysfunction
혈관연구회창립심포지움, 3 월 3 일, 2005 Novel Markers of Arterial Dysfunction Kwang Kon Koh, MD, FACC, FAHA Cardiology Gachon Medical School Incheon, Korea Atherosclerosis: A progressive process PHASE I: Initiation
More informationClassification of Endothelial Dysfunction. Stefano Taddei Department of Internal Medicine University of Pisa, Italy
Classification of Endothelial Dysfunction Stefano Taddei Department of Internal Medicine University of Pisa, Italy Pathogenesis of atherosclerosis from endothelial dysfunction to clinical disease endothelial
More informationThe Beneficial Role of Angiotensin- Converting Enzyme Inhibitor in Acute Myocardial Infarction
The Beneficial Role of Angiotensin- Converting Enzyme Inhibitor in Acute Myocardial Infarction Cardiovascular Center, Korea University Guro Hospital 2007. 4. 20 Seung-Woon Rha, MD, PhD Introduction 1.
More informationROLE OF INFLAMMATION IN HYPERTENSION. Dr Barasa FA Physician Cardiologist Eldoret
ROLE OF INFLAMMATION IN HYPERTENSION Dr Barasa FA Physician Cardiologist Eldoret Outline Inflammation in CVDs the evidence Basic Science in Cardiovascular inflammation: The Main players Inflammation as
More informationVascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital
Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries
More informationNovel function of NADPH oxidase in atherosclerosis. Yun Soo Bae Department of Life Science Ewha Womans University
Novel function of NADPH oxidase in atherosclerosis Yun Soo Bae Department of Life Science Ewha Womans University Recent understanding of ROS: act as second messengers e e Catalase/peroxidase O 2 H 2 O
More informationPathology of Coronary Artery Disease
Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology
More informationEndothelium. A typical endothelial cell is about 30mm long, Accounts for 1% or less of the arterial weight
Endothelium Discovered in 1845 A typical endothelial cell is about 30mm long, 10mm wide, and 0.2 3 mm thick Accounts for 1% or less of the arterial weight As recently as the late 1960s it was thought of
More informationRole of Alpha-lipoic acid(ala) and statin in vascular smooth muscle cell proliferation
Role of Alpha-lipoic acid(ala) and statin in vascular smooth muscle cell proliferation In-kyu Lee, M.D., Ph. D. Dept. of Internal Med, Keimyung Univ., School of Med. Taegu, Korea Oxidative Stress and Atherosclerosis
More informationEugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG
Diabetes Mellitus: Update 7 What is the unifying basis of this vascular disease? Eugene J. Barrett, MD, PhD Professor of Internal Medicine and Pediatrics Director, Diabetes Center and GCRC Health System
More informationDyslipidemia Endothelial dysfunction Free radicals Immunologic
ATHEROSCLEROSIS Hossein Mehrani Professor of Clinical Biochemistry Definition Atherosclerosis: Is a chronic inflammatory process characterized by plaque formation within the vessel wall of arteries and
More informationINFLAMMATION & REPAIR
INFLAMMATION & REPAIR Lecture 7 Chemical Mediators of Inflammation Winter 2013 Chelsea Martin Special thanks to Drs. Hanna and Forzan Course Outline i. Inflammation: Introduction and generalities (lecture
More informationThe 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories
The 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories Cardiac biomarkers in atherosclerosis Najma Asadi MD-APCP Ross and Colleagues in 1973: Response to Injury
More informationMacrovascular Disease in Diabetes
Macrovascular Disease in Diabetes William R. Hiatt, MD Professor of Medicine/Cardiology University of Colorado School of Medicine President, CPC Clinical Research Conflicts CPC Clinical Research (University-based
More informationNAM JUNE PAIK: Rhapsody in Video
NAM JUNE PAIK: Rhapsody in Video 혈관연구회추계학회 2007.10.13 Renin-angiotensin-aldosterone System Kwang Kon Koh, MD, FACC, FAHA Cardiology Gachon University Gil Medical Center Incheon, Korea Cytokines oxldl Ang
More informationLXIV: DRUGS: 4. RAS BLOCKADE
LXIV: DRUGS: 4. RAS BLOCKADE ACE Inhibitors Components of RAS Actions of Angiotensin i II Indications for ACEIs Contraindications RAS blockade in hypertension RAS blockade in CAD RAS blockade in HF Limitations
More informationInflammation and and Heart Heart Disease in Women Inflammation and Heart Disease
Inflammation and Heart Disease in Women Inflammation and Heart Disease What is the link between een inflammation and atherosclerotic disease? What is the role of biomarkers in predicting cardiovascular
More informationEndothelial Injury and Repair as a Working Paradigm
Endothelial Injury and Repair as a Working Paradigm A. Linke ESC Meeting 2010 UNIVERSITÄTLEIPZIG H ERZZEN TRUM Physiology of Endothelial Function: Regulation of Vascular Tone L-Arg. L-Arg. Agonists Shear
More informationChild born in year /3 will die before parents in US (diabetes)
Child born in year 2000-1/3 will die before parents in US (diabetes) ATP III identified 6 components of the metabolic syndrome that relate to CVD 1. Abdominal obesity 2. Atherogenic dyslipidemia (elevated
More informationCho et al., 2009 Journal of Cardiology (2009), 54:
Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness and Pulse Wave Velocity, and Increased Level of Inflammatory Markers are Associated with Variant Angina Cho et al., 2009 Journal
More informationand Restenosis Yangsoo Jang, MD, PhD. Yonsei University College of Medicine
PPAR- Agonist and In-Stent Restenosis Yangsoo Jang, MD, PhD. Yonsei University College of Medicine Peroxisome Proliferator- activated Receptors (PPAR) Lipid-activated transcription factors : => regulating
More informationDepression in Peripheral Artery Disease: An important Predictor of Outcome. Goals. Goals. Marlene Grenon, MD Assistant Professor of Surgery, UCSF
Depression in Peripheral Artery Disease: An important Predictor of Outcome There are no conflicts of interest Marlene Grenon, MD Assistant Professor of Surgery, UCSF UCSF VASCULAR SURGERY SYMPOSIUM SAN
More informationIschemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010
Ischemic Heart and Cerebrovascular Disease Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Relationships Between Diabetes and Ischemic Heart Disease Risk of Cardiovascular Disease in Different Categories
More informationVALUE OF ACEI IN THE MANAGEMENT OF HYPERTENSION
VALUE OF ACEI IN THE MANAGEMENT OF HYPERTENSION Dr Catherine BESEME Paris 6 th December 2005 6 th International Congress of Bangladesh Society of Medicine Hypertension is a risk factor at the source, with
More informationMetabolic Syndrome. DOPE amines COGS 163
Metabolic Syndrome DOPE amines COGS 163 Overview - M etabolic Syndrome - General definition and criteria - Importance of diagnosis - Glucose Homeostasis - Type 2 Diabetes Mellitus - Insulin Resistance
More informationMetabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine
Metabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine Setting the scene GB, 43 yo AA man followed for hypothyroidism returns on LT4 125 mcg/d and has a TSH=1.1
More informationInflammation: Novel Target for Cardiovascular Risk Reduction
Inflammation: Novel Target for Cardiovascular Risk Reduction Andrew Zalewski, M.D. Thomas Jefferson University, Philadelphia GlaxoSmithKline, Philadelphia Why inflammation? Population-based studies: low
More informationLeptin deficiency suppresses progression of atherosclerosis in apoe-deficient mice
Leptin deficiency suppresses progression of atherosclerosis in apoe-deficient mice Atherosclerosis, 2007 Chiba T, Shinozaki S, Nakazawa T, et al. Present by Sudaporn Pummoung Apolipoprotein E (apoe( apoe)
More informationCardiovascular System and Health. Chapter 15
Cardiovascular System and Health Chapter 15 Cardiovascular Disease Leading cause of death in U.S. Claims 1 life every 43 seconds Often, the first sign is a fatal heart attack Death Rates #1 CVD #2 Cancer
More informationSupplementary Figure 1:
Supplementary Figure 1: (A) Whole aortic cross-sections stained with Hematoxylin and Eosin (H&E), 7 days after porcine-pancreatic-elastase (PPE)-induced AAA compared to untreated, healthy control aortas
More informationCardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century November 2, 2016
Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century November 2, 2016 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process
More informationArteriosclerosis & Atherosclerosis
Arteriosclerosis & Atherosclerosis Arteriosclerosis = hardening of arteries = arterial wall thickening + loss of elasticity 3 types: -Arteriolosclerosis -Monckeberg medial sclerosis -Atherosclerosis Arteriosclerosis,
More informationUpdate On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID?
Update On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID? Karen Aspry, MD, MS, ABCL, FACC Assistant Clinical Professor of Medicine Warren Alpert Medical School of Brown
More informationEstrogens vs Testosterone for cardiovascular health and longevity
Estrogens vs Testosterone for cardiovascular health and longevity Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Women vs Men Is there a difference in
More informationCardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009
Cardiovascular disease, studies at the cellular and molecular level Linda Lowe Krentz Bioscience in the 21 st Century September 23, 2009 Content Introduction The number 1 killer in America Some statistics
More informationEicosapentaenoic Acid and Docosahexaenoic Acid: Are They Different?
Eicosapentaenoic Acid and Docosahexaenoic Acid: Are They Different? Trevor A Mori, Ph.D., Professor, School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Perth,
More informationΦΛΕΓΜΟΝΗ ΚΑΙ ΔΙΑΒΗΤΗΣ
ΦΛΕΓΜΟΝΗ ΚΑΙ ΔΙΑΒΗΤΗΣ ΘΩΜΑΣ ΠΑΠΑΔΟΠΟΥΛΟΣ, MD, PHD ΕΠΕΜΒΑΤΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ ΙΑΤΡΙΚΟ ΔΙΑΒΑΛΚΑΝΙΚΟ ΚΕΝΤΡΟ Inflammation as a cause of disease has entered the popular imagination. Diet ( macronutrients )
More informationAmerican Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida
The 21 st Century Paradigm Shift: Prevention Rather Than Intervention for the Treatment of Stable CHD The Economic Burden of Cardiovascular Diseases Basil Margolis MD, FACC, FRCP Director, Preventive Cardiology
More informationWho Cares About the Past?
Risk Factors, the New Calcium Score, Rheology and Atherosclerosis Progression Arthur Agatston 2/21/15 The Vulnerable Plaque vs. Plaque Burden CT Angiogram Is There a Role for Coronary Artery Calcium Scoring
More informationStress and Disease. Chapter 8. Elsevier items and derived items 2008 by Mosby, Inc., an affiliate of Elsevier Inc.
Stress and Disease Chapter 8 Stress A person experiences stress when a demand exceeds a person s coping abilities, resulting in reactions such as disturbances of cognition, emotion, and behavior that can
More informationA real life example In human studies, we quantify ~120 plasma related proteins Monocytes MMP9 Macrophages TNFα IL1ß platelet derived growth factor IFNγ MMP1 MMP8 MMP13 Myeloid Related Protein14 CD40
More informationCardiovascular Complications of Diabetes
VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary
More informationCan seal oil contribute to better human health?
Can seal oil contribute to better human health? Bjarne Østerud and Edel O. Elvevoll, Faculty of Medicine and NFH, University of Tromsø E-mail: bjarne@fagmed. Historical background Old food lore of seafood
More informationVulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark
Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem or Systemic Disease Erling Falk, Denmark Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem
More informationTreatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center
Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment
More informationPlatelet function in diabetes
Platelet function in diabetes Agneta Siegbahn, MD, PhD, FESC Professor Clinical Coagulation Science Department of Medical Sciences and Uppsala Clinical Research Center Uppsala University Disclosures: None
More informationRole of Inflammation in Pulmonary Hypertension
Role of Inflammation in Pulmonary Hypertension K. R. Stenmark University of Colorado Denver, USA Prominent Fibroproliferative Changes are Observed in the Lung Vasculature of Infants With Pulmonary Arterial
More informationVulnerable Plaque. Atherothrombosis
Vulnerable Plaque Nuove acquisizioni sull'aterosclerosi: placca vulnerabile Marina Camera Dip. Scienze Farmacologiche, Facoltà di Farmacia, Università degli Studi di Milano & Laboratorio di Biologia Cellulare
More informationFigure 13-1: Antiplatelet Action of Aspirin (Modified After Taneja et.al 2004) ASPIRIN RESISTANCE
CHAPTER 13 ASPIRIN Action Aspirin Resistance Aspirin Dose Therapeutic Efficacy - Secondary prevention - Acute coronary syndromes - Primary prevention Limitations and Side Effects Aspirin Aspirin should
More informationCell-Derived Inflammatory Mediators
Cell-Derived Inflammatory Mediators Introduction about chemical mediators in inflammation Mediators may be Cellular mediators cell-produced or cell-secreted derived from circulating inactive precursors,
More information10/17/16. Assessing cardiovascular risk through use of inflammation testing
Assessing cardiovascular risk through use of inflammation testing Anthony L. Lyssy, DO Medical Director and Managing Partner Diamond Physicians Dallas, TX Response to Injury Hypothesis Injury Response
More informationBerries and Cardiovascular Health
Berries and Cardiovascular Health Britt Burton-Freeman, PhD Institute for Food Safety and Health Illinois Institute of Technology bburton@iit.edu Berry Health Benefits Symposium Westlake Village CA, 2011
More informationDyslipedemia New Guidelines
Dyslipedemia New Guidelines New ACC/AHA Prevention Guidelines on Blood Cholesterol November 12, 2013 Mohammed M Abd El Ghany Professor of Cardiology Cairo Universlty 1 1 0 Cholesterol Management Pharmacotherapy
More informationWelcome! Mark May 14, Sat!
Welcome! Mark May 14, Sat! Do We Have All Answers with Statins In Treating Patients with Hyperlipidemia? Kwang Kon Koh, MD, PhD, FACC, FAHA Cardiology, Gil Heart Center, Gachon Medical School, Incheon,
More information12/18/2009 Resting and Maxi Resting and Max mal Coronary Blood Flow 2
Coronary Artery Pathophysiology ACS / AMI LeRoy E. Rabbani, MD Director, Cardiac Inpatient Services Director, Cardiac Intensive Care Unit Professor of Clinical Medicine Major Determinants of Myocardial
More informationTerm-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY
MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple
More informationDyslipidaemia. Is there any new information? Dr. A.R.M. Saifuddin Ekram
Dyslipidaemia Is there any new information? Dr. A.R.M. Saifuddin Ekram PhD,FACP,FCPS(Medicine) Professor(c.c.) & Head Department of Medicine Rajshahi Medical College Rajshahi-6000 New features of ATP III
More informationObesity is related to a higher inflammatory responsive state of circulating cells after stimulation of toll like receptor 2 and 4.
Toll Like Receptor Response and traditional risk factors for atherosclerosis: Obesity is related to a higher inflammatory responsive state of circulating cells after stimulation of toll like receptor 2
More informationThe Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Update 2013 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine Denver Health
More informationBlood Vessel Mechanics
Blood Vessel Mechanics Ying Zheng, Ph.D. Department of Bioengineering BIOEN 326 11/01/2013 Blood Vessel Structure A Typical Artery and a Typical Vein Pressure and Blood Flow Wall stress ~ pressure Poiseuille
More informationDiabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center
Diabetes and Heart Disease Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center No conflicts of interest or financial relationships to disclose. 2 What s the problem??
More informationObesity mediated hypertension and renal dysfunction
Obesity mediated hypertension and renal dysfunction Gergely Bodor Marion Hervouet Nicky Honnef Mariarosaria Malgadi Julie Robert Tutor: Pr Alina Parvu Objectives 1. Introduction 2. Renal structural and
More information9/18/2017 DISCLOSURES. Consultant: RubiconMD. Research: Amgen, NHLBI OUTLINE OBJECTIVES. Review current CV risk assessment tools.
UW MEDICINE UW MEDICINE UCSF ASIAN TITLE HEALTH OR EVENT SYMPOSIUM 2017 DISCLOSURES Consultant: RubiconMD ESTIMATING CV RISK IN ASIAN AMERICANS AND PREVENTION OF CVD Research: Amgen, NHLBI EUGENE YANG,
More informationPCTH 400. Endothelial dysfunction and cardiovascular diseases. Blood vessel LAST LECTURE. Endothelium. High blood pressure
PCTH 400 LAST LECTURE Endothelial dysfunction and cardiovascular diseases. Classic Vascular pharmacology -chronic -systemic Local Vascular pharmacology -acute -targeted High blood pressure Blood pressure
More information9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t?
Primary Prevention of Heart Disease: What works? What doesn t? Samia Mora, MD, MHS Associate Professor, Harvard Medical School Associate Physician, Brigham and Women s Hospital October 2, 2015 Financial
More informationPathophysiology of Lipid Disorders
Pathophysiology of Lipid Disorders Henry Ginsberg, M.D. Division of Preventive Medicine and Nutrition CHD in the United States CHD is the single largest killer of men and women 12 million have history
More informationPCSK9 Inhibitors and Modulators
PCSK9 Inhibitors and Modulators Pam R. Taub MD, FACC Director of Step Family Cardiac Rehabilitation and Wellness Center Associate Professor of Medicine UC San Diego Health System Disclosures Speaker s
More informationLong-Term Complications of Diabetes Mellitus Macrovascular Complication
Long-Term Complications of Diabetes Mellitus Macrovascular Complication Sung Hee Choi MD, PhD Professor, Seoul National University College of Medicine, SNUBH, Bundang Hospital Diabetes = CVD equivalent
More informationLipoprotein Particle Profile
Lipoprotein Particle Profile 50% of people at risk for HEART DISEASE are not identified by routine testing. Why is LPP Testing The Most Comprehensive Risk Assessment? u Provides much more accurate cardiovascular
More informationhttp://noodlemaz.wordpress.com/category/science/cancer/ Outline Introduction Serious nature of Cardiovascular Disease (CVD) How to prevent CVD? The disease process Damage and plaque development Current
More informationThe aorta is an integral part of the cardiovascular system and should not be considered as just a conduit for blood supply from the heart to the
The aorta is an integral part of the cardiovascular system and should not be considered as just a conduit for blood supply from the heart to the limbs and major organs. A range of important pathologies
More informationC-reactive protein. ; Friend or Foe? Ki Hoon Han MD PhD Asan Medical Center Seoul, Korea
C-reactive protein ; Friend or Foe? Ki Hoon Han MD PhD Asan Medical Center Seoul, Korea I. Inflammation and atherogenesis Atherosclerosis is an inflammatory disease Recruitment of Blood Monocytes by Endothelial
More informationSYNDROME IN WOMEN IN PERIMINOPAUSE
УДК 257.36 Kodirova G.I., Kholikova D.S., Toshtemirova I.M. Andijan State Medical Institute Uzbekistan, Andijan сity Кодирова Г.И., Холикова Д.С., Тоштемирова И.М. Андижанский государственный медицинский
More informationPATIENTS AND METHODS:
BACKGROUND: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by erosive synovitis that involves peripheral joints and implicates an important influence in the quality
More informationDiabetes and Heart Disease
Diabetes and Heart Disease Sarah Alexander, MD Assistant Professor of Medicine Division of Cardiology Rush University Medical Center 2/8/2017 Rush is a not-for-profit health care, education and research
More informationJanet B. Long, MSN, ACNP, CLS, FAHA, FNLA Rhode Island Cardiology Center
Primary and Secondary Prevention of Coronary Artery Disease: What is the role of non statin drugs (fenofibrates, fish oil, niacin, folate and vitamins)? Janet B. Long, MSN, ACNP, CLS, FAHA, FNLA Rhode
More informationAnnals of RSCB Vol. XVI, Issue 1
THE STUDY OF PROTHROBOTIC STATE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CARDIOVASCULAR DISEASES Oana Bădulescu 1, Codruţa Bădescu 2, Manuela Ciocoiu 1, Magda Bădescu 1 1 DEPARTMENT OF PATHOPHYSIOLOGY;
More informationStatins and endothelium function
Statins and endothelium function Matthias Endres Berlin, Germany Klinik und Poliklinik für Neurologie Conflict of interest: research grant from AstraZeneca from prevention to acute therapy... Pleiotropic
More informationTHE CARDIOVASCULAR INFLAMMATORY CONTINUUM DR AB MAHARAJ
THE CARDIOVASCULAR INFLAMMATORY CONTINUUM DR AB MAHARAJ Disclosures: On National Advisory Boards of: (1) Pfizer Pharmaceuticals (2) MSD (3) Roche Pharmaceuticals (4) Abbott International: AfME Rheumatology
More informationInflammation in heart failure: biomarker, bystander or mediator
Inflammation in heart failure: biomarker, bystander or mediator Novel matricellular proteins to target Javier Díez, MD, PhD. Centre of Applied Medical Research and University Clinic School of Medicine,
More informationHow would you manage Ms. Gold
How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56
More informationComplications of Diabetes mellitus. Dr Bill Young 16 March 2015
Complications of Diabetes mellitus Dr Bill Young 16 March 2015 Complications of diabetes Multi-organ involvement 2 The extent of diabetes complications At diagnosis as many as 50% of patients may have
More informationATHEROSCLEROSIS زيد ثامر جابر. Zaid. Th. Jaber
ATHEROSCLEROSIS زيد ثامر جابر Zaid. Th. Jaber Objectives 1- Review the normal histological features of blood vessels walls. 2-define the atherosclerosis. 3- display the risk factors of atherosclerosis.
More informationAcute coronary syndrome. Dr LM Murray Chemical Pathology Block SA
Acute coronary syndrome Dr LM Murray Chemical Pathology Block SA13-2014 Acute myocardial infarction (MI) MI is still the leading cause of death in many countries It is characterized by severe chest pain,
More informationCardiovascular disease, studies at the cellular and molecular level. Linda Lowe Krentz Bioscience in the 21 st Century October 4, 2010
Cardiovascular disease, studies at the cellular and molecular level Linda Lowe Krentz Bioscience in the 21 st Century October 4, 2010 Content Introduction The number 1 killer in America Some statistics
More informationThe Role of Massage in Blood Circulation, Pain Relief, and the Recovery Process: Implications of Existing Research
The Role of Massage in Blood Circulation, Pain Relief, and the Recovery Process: Implications of Existing Research I. Basic Physiology of Circulation A. The Vascular Endothelium The endothelium is a complex
More information2/10/2014. The Vascular Biology of Eating. Robert A. Vogel, MD Clinical Professor of Medicine University of Colorado Denver
//4 The Vascular Biology of Eating Robert A. Vogel, MD Clinical Professor of Medicine University of Colorado Denver Disclosure: Consultant Pritikin Longevity Center Histological and Vascular Biological
More informationMetabolic syndrome, obesity, diabetes, and theier implications
Metabolic syndrome, obesity, diabetes, and theier implications jan.krtil@lf1.cuni.cz Institute of Medical Biochemistry and Laboratory Diagnostics &1 st Department of Medicine Diabetes mellitus type 2 (T2DM)
More informationInnate Immunity in Atherosclerosis
Innate Immunity in Atherosclerosis Peter Libby Brigham & Women s Hospital Harvard Medical School IAS Amsterdam May 26, 2015 ACS Stable demand angina Characteristics of Atherosclerotic Plaques Associated
More informationDiabetes and the Heart
Diabetes and the Heart Association of Specialty Professors April 4, 2013 Jorge Plutzky, MD Co-Director, Preventive Cardiology Director, The Lipid Clinic Cardiovascular Division Brigham and Women s Hospital
More informationDECLARATION OF CONFLICT OF INTEREST. No disclosures
DECLARATION OF CONFLICT OF INTEREST No disclosures micrornas: Role in progression of atherosclerosis Christian Weber Institute for Cardiovascular Prevention (IPEK) Ludwig-Maximilians-University Munich
More informationQuinn Capers, IV, MD
Heart Attacks Mended Hearts Presentation, January, 2017 Quinn Capers, IV, MD Associate Professor of Medicine (Cardiovascular Medicine) Director, Transradial Coronary Interventions Division of Cardiovascular
More information13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:
CARDIOVASCULAR DISEASES (CVD) and NUTRITION Major cause of morbidity & mortality in Canada & other developed countries e.g., majority of approved health claims on food labels relate to lowering CVD Relation
More informationBasic Mechanisms of Atherosclerosis and Plaque Rupture: Clinical Implications
12 th Annual Cardiovascular Disease Prevention Symposium February 8, 2013 KEYNOTE ADDRESS Basic Mechanisms of Atherosclerosis and Plaque Rupture: Clinical Implications Ira Tabas, M.D., Ph.D. Richard J.
More information